We are monitoring the impact of COVID-19 on Europe Cervical Cancer Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 773
Share on
Share on

Europe Cervical Cancer Diagnostics and Therapeutics Market Research Report - Segmented By Diagnostics Test, Methods, Therapies, End-users & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecast (2021 to 2026)

Pulished: April, 2021
ID: 773
Pages: 137

Europe Cervical Cancer Diagnostics and Therapeutics Market Size (2021 to 2026)

The Europe Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 1079.25 Million in 2021. It is projected to reach USD 1275.63 Million by 2026, at a CAGR of 3.40% during the forecast period from 2021 to 2026.  

The growing population and the Increase in prevalence of cervical cancer among women are majorly driving the cervical cancer diagnostics and therapeutics market in Europe. However, as in this region, about 33,000 cases of cervical cancer were diagnosed with 15,000 fatalities, as the coverage of human papillomavirus (HPV) is low in the countries with the most significant prevalence and screening effectiveness varies in European countries. Therefore, increasing prevalence is increasing the demand for cervical cancer diagnostics and therapeutics in the market.

In addition, an increase in the pipeline of cervical cancer screening tests is also driving the market growth of cervical cancer diagnostics and therapeutics. The growing technological advancements for developing innovative and effective diagnostics procedures for treating cervical cancer and raising awareness about disease prevention are likely to propel market growth.

Furthermore, the Increase in investment and fundings from government and non-government firms in research activities for developing effective treatment and prevention methods for cervical cancer is expected to drive the market growth.

However, the Increase in the high costs of the treatment and therapies and the lack of trained and skilled individuals for operating screening tests is limiting the growth rate of the European cervical diagnostics and therapeutics market. Also, the lack of awareness among the people about the pre-diagnosing effects and HPV vaccines in the region also restraints the growth of the market. In addition, the strict government rules and regulations with stringent approval processes make the entry of the product difficult in the market, hampers the growth of the cervical cancer diagnostics and therapeutics market.

This research report on the European cervical cancer diagnostics and therapeutics market has been segmented and sub-segmented into the following categories:

By Diagnostics Test:

  • Pap Smear Test
  • HPV Testing
  • Colposcopy
  • Cervical Cancer Biopsy

By Methods:

  • Molecular Method
  • Cytopathological Method
  • Physical Method

By Therapies:

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Others

By End-users:

  • Hospitals
  • Laboratories
  • Independent Physicians
  • Clinics
  • Others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European market is estimated to be the second-largest regional market in the global cervical cancer diagnostics and therapeutics market during the forecast period. The growing population and lack of effective and efficient screening programs for treating and detecting pre-cancerous conditions are the leading causes that increase the demand for proper cervical cancer diagnostics and therapeutics. As a result, the countries such as Germany, UK, France, and Italy significantly contribute to the regional market growth.

In this region, the UK accounts for around 3200 new cervical cancer cases every year due to lack of access and proper cervical cancer prevention and control services. But this has seen a significant increase in the market due to the rising awareness about prevention and controlling the spread of cancer. In addition, the presence of various treatments or tests available in the market also contributes to growth in the market.

On the other hand, an increase in initiatives for arranging programs associated with cervical cancer pre- diagnosing benefits and preventive measures, increase in the government and non-government organization investments in research and development activities are also driving the growth of cervical cancer diagnostics and therapeutics in the market.

KEY MARKET PLAYERS:

A few of the promising companies operating in the European cervical cancer diagnostics and therapeutics market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, and Volition Rx.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By diagnostics test                 

                             5.1.1 Pap smear test     

                             5.1.2 HPV testing           

                             5.1.3 Colposcopy           

                             5.1.4 Cervical cancer biopsy      

              5.2 By methods                            

                             5.2.1 Molecular method             

                             5.2.2 Cytopathological method 

                             5.2.3 Physical method  

              5.3 By therapies                           

                             5.3.1 Surgery    

                             5.3.2 Radiation therapy

                             5.3.3 Chemotherapy     

                             5.3.4 Other therapies   

              5.4 By end-users                          

                             5.4.1 Hospitals 

                             5.4.2 Laboratories         

                             5.4.3 Independent physicians   

                             5.4.4 Clinics      

                             5.4.5 Other end-users  

6. Geographical Analysis                                         

                             6.1 Introduction             

                             6.2 U.K 

                             6.3 Spain           

                             6.4 Germany    

                             6.5 Italy             

                             6.6 France         

7. Pipeline Product Analysis                                    

              7.1 Overview                  

              7.2 Pipeline Development Landscape                   

              7.3 Molecular Targets in the Pipeline                   

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target    

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 Abbott Diagnostics                

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Alere                          

              9.3 Beckman Coulter                   

              9.4 Clinical Genomics                  

              9.5 Companion Dx                       

              9.6 EDP Biotech              

              9.7 Epigenomics AG                     

              9.8 Exact Sciences                        

              9.9 Fujirebio                    

              9.10 Genomic Tree                      

              9.11 Metabiomics                        

              9.12 Siemens Healthcare                          

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  2. Europe Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  3. Europe Cervical Cancer Pap smear test Market By Region, From 2021 to 2026 (USD Million)
  4. Europe Cervical Cancer HPV testing Market By Region, From 2021 to 2026 (USD Million)
  5. Europe Cervical Cancer Colposcopy Market By Region, From 2021 to 2026 (USD Million)
  6. Europe Cervical cancer biopsy Market By Region, From 2021 to 2026 (USD Million)
  7. Europe Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  8. Europe Molecular method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  9. Europe Cytopathological method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  10. Europe Physical method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  11. Europe Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  12. Europe Surgery Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  13. Europe Radiation therapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  14. Europe Chemotherapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  15. Europe Other therapies Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  16. Europe Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)
  17. Europe Hospitals Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  18. Europe Laboratories Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  19. Europe Independent physicians Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  20. Europe Clinics Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2021 to 2026 (USD Million)
  21. Europe Other end-users Market By Region, From 2021 to 2026 (USD Million)
  22. U.K Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  23. U.K Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  24. U.K Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  25. U.K Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)
  26. Spain Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  27. Spain Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  28. Spain Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  29. Spain Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)
  30. Germany Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  31. Germany Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  32. Germany Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  33. Germany Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)
  34. Italy Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  35. Italy Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  36. Italy Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  37. Italy Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)
  38. France Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2021 to 2026 (USD Million)
  39. France Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2021 to 2026 (USD Million)
  40. France Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2021 to 2026 (USD Million)
  41. France Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample